| pubmed-article:9802740 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9802740 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9802740 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9802740 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:9802740 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:9802740 | lifeskim:mentions | umls-concept:C0246689 | lld:lifeskim |
| pubmed-article:9802740 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:9802740 | pubmed:dateCreated | 1999-1-14 | lld:pubmed |
| pubmed-article:9802740 | pubmed:abstractText | The objective of the study was to assess the efficacy and safety of repaglinide compared with placebo in the treatment of patients with type 2 diabetes. | lld:pubmed |
| pubmed-article:9802740 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9802740 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9802740 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9802740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9802740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9802740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9802740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9802740 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9802740 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9802740 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:GoldbergR BRB | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:HuangW CWC | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:LucasC PCP | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:BrodowsR GRG | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:EinhornDD | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:RendellM SMS | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:DamsboPP | lld:pubmed |
| pubmed-article:9802740 | pubmed:author | pubmed-author:StrangePP | lld:pubmed |
| pubmed-article:9802740 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9802740 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:9802740 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9802740 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9802740 | pubmed:pagination | 1897-903 | lld:pubmed |
| pubmed-article:9802740 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:meshHeading | pubmed-meshheading:9802740-... | lld:pubmed |
| pubmed-article:9802740 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9802740 | pubmed:articleTitle | A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes. | lld:pubmed |
| pubmed-article:9802740 | pubmed:affiliation | Diabetes Research Institute, University of Miami School of Medicine, Florida 33136, USA. | lld:pubmed |
| pubmed-article:9802740 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9802740 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9802740 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9802740 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9802740 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:9802740 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9802740 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9802740 | lld:pubmed |
